ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Modesto At-Home Testing System For Obstructive Sleep Apnea: Device Update

At Home Sleep Apnea Testing announces the latest iteration of the WatchPAT One device, now available to residents across California's Central Coast and Central Valley.

-- Recognizing that many regions along California's Central Coast and Central Valley have limited access to sleep disorder specialists, At Home Sleep Apnea Testing has announced the latest iteration of its WatchPAT One device. The update is designed to help residents in areas between coastal hubs like Santa Maria, Salinas, and Monterey, as well as inland towns such as Modesto, Visalia, Hanford, and Madera.

More details can be found at https://athomesleepapneatesting.com/innovation-in-the-night-latest-advances-in-sleep-apnea-treatment/

At Home Sleep Apnea Testing’s enhanced WatchPAT One device requires a simple finger attachment to provide data, with results sent to sleep experts and analyzed within a few days. The company states that this approach addresses unmet healthcare needs in underserved communities, eliminating the requirement for hospital sleep lab visits that would otherwise mean long-distance travel or extended wait times for specialist appointments.

A 2024 study published in Respiratory Medicine estimated that 83.7 million American adults are living with obstructive sleep apnea, representing roughly 32 percent of adults aged 20 and older. Despite this substantial prevalence, the research emphasizes that sleep apnea remains largely undiagnosed, highlighting an urgent need for improved screening and diagnosis options.

In response to this widespread rate of under-diagnosis, the updated device is intended to remove common barriers to testing by eliminating the need for facility-based appointments. At Home Sleep Apnea Testing notes that the streamlined process allows individuals to complete testing in familiar surroundings, which the company states can better reflect natural sleep patterns compared to unfamiliar clinical environments.

"Unlike more complicated diagnostic devices, the WatchPAT home sleep study device is easy to use, accurate, and reliable," a company representative explained. "This environment is more representative of your personal sleep habits, and the simple operation ensures the best possible sleep experience."

About At Home Sleep Apnea Testing

The company's Medical Director, Ronald A. Popper MD, DABSM, FAASM, has been practicing sleep medicine since 1984. He is also the founder and Medical Director of the Southern California Pulmonary & Sleep Disorders Medical Center in Thousand Oaks, which has been fully accredited by the American Academy of Sleep Medicine since 1985.

"I was researching at-home kits and this one had incredible reviews," one client recently stated. "The experience was straightforward from beginning to end. It took less than a week to complete the test and receive a diagnosis, and I felt much more comfortable sleeping in my own bed than I would have at an unfamiliar facility."

Interested parties can find more information by visiting https://athomesleepapneatesting.com/simplify-life-with-at-home-sleep-apnea-test/

Contact Info:
Name: Ronald A. Popper, MD, FCCP, FAASM, DABSM
Email: Send Email
Organization: At Home Sleep Apnea Testing
Address: 317 S. Moorpark Rd, Thousand Oaks, CA 91361, Thousand Oaks, California 91361, United States
Website: https://athomesleepapneatesting.com/

Source: PressCable

Release ID: 89180604

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.38
+1.09 (0.44%)
AAPL  259.37
+0.33 (0.13%)
AMD  203.17
-1.51 (-0.74%)
BAC  55.85
-0.33 (-0.59%)
GOOG  329.14
+3.13 (0.96%)
META  653.06
+7.00 (1.08%)
MSFT  479.28
+1.17 (0.24%)
NVDA  184.86
-0.18 (-0.10%)
ORCL  198.52
+9.37 (4.95%)
TSLA  445.01
+9.21 (2.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.